Displaying archives for 2017 February:

Check Out the Latest News From ALCMI

Posted by Bradley Newton on February 28th, 2017 |

The Addario Lung Cancer Medical Institute’s (ALCMI) CASTLE study provides a unique foundational resource enabling scientists to ask and answer critical questions around the biology of lung cancer, and has directly facilitated a number of innovative research efforts. The CASTLE specimens and data are being used to the benefit of patients while advancing lung cancer… Read More

Are you a ROS1+ patient?

Posted by Bradley Newton on February 24th, 2017 |

ALCF launched its Global ROS1 Initiative in 2016 to accelerate research into this understudied type of cancer. Learn more about how YOU can participate as we add the new ROS1 Biorepository Project.

Deadly, rare lung cancer finds big foe: Patients with little to lose

Posted by ALCF Staff on February 8th, 2017 |

The San Francisco Business Times recently featured ALCF for the work we are doing, at the request of our patients, to study the ROS1 gene… Read More